Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/

Genetic Testing

Review Essay: Genetic Testing Is Different

Evidence Reports/Technology Assessments

Evidence Report/Technology Assessment, No. 209:
Multigene Panels in Prostate Cancer Risk Assessment
Evidence Report/Technology Assessment: Number 186:
Family History and Improving Health
Evidence Report/Technology Assessment: Number 180:
Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism
Evidence Report/Technology Assessment: Number 160:
Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes

Technology Assessments:
Update on Mapping the Landscape of Genetic Tests for Non-Cancer Diseases/Conditions
Update of Horizon Scans of Genetic Tests Currently Available for Clinical Use in Cancers

Top of Page Top of Page

Preventive Services

Task Force Recommendations:
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility Exit Disclaimer (2005)

Top of Page Top of Page

Research Findings

Research Activities, December 2012:
Genetic risk for obesity in children boosts risk for obesity in adulthood
Research Activities, October 2012:
AHRQ reviews evidence on multigene panels for prostate cancer risk assessment
Research Activities, April 2012:
Not enough evidence to recommend fecal DNA testing for adults at average risk for colorectal cancer
Research Activities, May 2011:
Genotype information can make the predicted therapeutic dose of warfarin more accurate
Research Activities, March 2011:
In vitro fertilization has advantages over natural conception for couples who both carry the cystic fibrosis trait
Research Activities, October 2010:
Laboratory tests can accurately detect two clotting-factor mutations that raise risk of blood clots
Research Activities, May 2010:
Cost-effectiveness analysis supports genetic testing before patients with metastatic colorectal cancer are given irinotecan
Racial and ethnic minority groups are less aware than whites of genetic testing for cancer risk

Top of Page Top of Page

 

AHRQAdvancing Excellence in Health Care